Skip to main content

News

Where hypotheses become headlines: Featured coverage of the breakthroughs—and the people—driving our research forward

For media inquiries, email us: [email protected]


Featured News
The Scripps Research scientists leading the Huang Foundation-supported projects. From left: Terrence Messmer, Sarah Burbach, Matthew Holcomb, Bryan Briney, Stefano Forli, Benjamin Cravatt, Christopher Parker, Andrew Ward and Charles Bowman.
News

Scripps Research garners major support for AI innovations in biomedicine with compute grant from Jen-Hsun and Lori Huang Foundation

Chi-Huey Wong.
News

Scripps Research professor Chi-Huey Wong to receive ACS Alfred Bader Award

Filter by:
  • Scripps Research tracks prevalence of new COVID-19 variants with daily reports on Outbreak.info
    News

    Scripps Research tracks prevalence of new COVID-19 variants with daily reports on Outbreak.info

    To drive global research efforts, the Center for Viral Systems Biology at Scripps Research is tracking the prevalence of new variants of SARS-CoV-2 and making this information publicly available.

  • Chemist Hans Renata named 2021 Sloan Research Fellow
    News

    Chemist Hans Renata named 2021 Sloan Research Fellow

    A Scripps Research chemist who employs enzymes as tools to assemble useful natural compounds has been awarded a prestigious 2021 Sloan Research Fellowship for his work.

  • Scientists identify protein that may be silent cause of ‘iron overload’
    News

    Scientists identify protein that may be silent cause of ‘iron overload’

    A sensor protein plays an unexpected and important role in regulating iron levels in the body, according to a new study.

  • Scientists urge for investment now in highly potent vaccines to prevent the next pandemic
    News

    Scientists urge for investment now in highly potent vaccines to prevent the next pandemic

    Warning that the next fast-spreading virus may not be as accommodating as the coronavirus driving COVID-19, they call for a new approach to pandemic preparedness.  

  • Scripps Research and Tempus collaborate to study how individual blood sugar levels vary
    News

    Scripps Research and Tempus collaborate to study how individual blood sugar levels vary

    The study will leverage genomics and digital technologies to better understand factors that contribute to obesity and type 2 diabetes. 

  • First-in-human clinical trial confirms novel HIV vaccine approach developed by IAVI and Scripps Research
    News

    First-in-human clinical trial confirms novel HIV vaccine approach developed by IAVI and Scripps Research

    A phase 1 trial testing a vaccine to prevent HIV has produced promising results, stimulating production of rare immune cells that begin the process of generating antibodies against the fast-mutating virus.

  • Experimental vaccine blunts the deadliest of synthetic opioids
    News

    Experimental vaccine blunts the deadliest of synthetic opioids

    In early tests, the vaccine was able to diminish fatal respiratory effects of fentanyl and carfentanil.

  • Ozanimod accepted for priority review by FDA for the treatment of ulcerative colitis
    News

    Ozanimod accepted for priority review by FDA for the treatment of ulcerative colitis

    The priority review is based on results from a placebo-controlled Phase 3 trial evaluating ozanimod as a therapy for moderately to severely active ulcerative colitis.

  • Kenan Trust contributes $1.8 million to science education at Scripps Research, Florida
    News

    Kenan Trust contributes $1.8 million to science education at Scripps Research, Florida

    Scripps Research, Florida has received a $1.8 million philanthropic gift from the William R. Kenan, Jr. Charitable Trust to support science education training.

  • Unraveling the mystery of Gao, a protein implicated in movement disorders
    News

    Unraveling the mystery of Gao, a protein implicated in movement disorders

    Through their discovery, scientists expanded what's known about how the brain controls muscles and may have opened the door to potential treatments for children with certain rare disorders.

  • Toward safer steroids: Scientists devise process for making precision anti-inflammatory medicines
    News

    Toward safer steroids: Scientists devise process for making precision anti-inflammatory medicines

    Scripps Research scientists engineer potentially safer glucocorticoids, a group of drugs used to treat COVID-19, auto-immune disease, and many other conditions.

  • Harvard Business Review Op-ed: Planning for the Next Pandemic
    News

    Harvard Business Review Op-ed: Planning for the Next Pandemic

    Scripps Research President Peter Schultz calls for investment in the development of anti-viral drugs to combat viruses most likely to cause the next global pandemic.

  • Eric Topol to receive Gold Foundation medal for humanism in healthcare
    News

    Eric Topol to receive Gold Foundation medal for humanism in healthcare

    Topol to be honored alongside Drs. Anthony Fauci and Wayne Riley, as well as hundreds of healthcare professionals for their dedication and compassion during the COVID-19 crisis.  

  • Gene regulator pumps iron to control sleep, inflammation and more, study finds
    News

    Gene regulator pumps iron to control sleep, inflammation and more, study finds

    Structural studies reveal the role of an iron-rich molecule, heme, in bringing together gene transcription factors involved in sleep, immunity and metabolism.

  • Ardem Patapoutian receives 2021 Frontiers of Knowledge Award from BBVA
    News

    Ardem Patapoutian receives 2021 Frontiers of Knowledge Award from BBVA

    Patapoutian is recognized for world-class research that provided the molecular basis for how temperature and pressure are perceived.

  • At least 1 in 3 people infected with COVID-19 never develop symptoms, according to new analysis
    News

    At least 1 in 3 people infected with COVID-19 never develop symptoms, according to new analysis

    Findings suggest COVID-19 testing should be expanded to those without symptoms who may be unknowingly spreading the virus to others.

  • Scripps Research CEO Peter Schultz wins National Academy of Sciences’ chemistry award for extraordinary scientific achievements
    News

    Scripps Research CEO Peter Schultz wins National Academy of Sciences’ chemistry award for extraordinary scientific achievements

    Schultz has made many innovative and pioneering contributions to the interface between chemistry and biology, including the rational expansion of the genetic code. 

  • ‘Transient forgetting’ controlled by dopamine circuits, scientists find
    News

    ‘Transient forgetting’ controlled by dopamine circuits, scientists find

    Distraction can make you momentarily forget things. But how? Davis lab at Scripps Research, Florida uncovers a mechanism in fruit flies.

  • Answering the Big Questions with Science, Simplified
    News

    Answering the Big Questions with Science, Simplified

    How a graduate student’s scientific illustrations have gone viral, leading to an award-winning video series.

  • Scripps Research kicks off 2021 virtual Front Row lecture series
    News

    Scripps Research kicks off 2021 virtual Front Row lecture series

    Scripps Research President and CEO Peter Schultz, PhD, kicks off the 2021 Front Row lecture series with a talk on how the institute is accelerating drug development. 

    Events
  • Scripps Research, UC San Diego find first evidence of UK coronavirus variant in California
    News

    Scripps Research, UC San Diego find first evidence of UK coronavirus variant in California

    Since the team's discovery, several additional cases of the B.1.1.7 coronavirus variant have been identified across California.

  • Targeting muscle cells’ insulin receptors allows more efficient gene therapy
    News

    Targeting muscle cells’ insulin receptors allows more efficient gene therapy

    A new approach to gene therapy improves the efficiency of gene delivery.

  • How Scripps Research helped map the course for today’s COVID-19 vaccines
    News

    How Scripps Research helped map the course for today’s COVID-19 vaccines

    Structural biologists developed the first detailed images of the coronavirus spike protein and then created a way to stabilize the protein for vaccines.  

  • Discovery boosts theory that life on Earth arose from RNA-DNA mix
    News

    Discovery boosts theory that life on Earth arose from RNA-DNA mix

    In addition to addressing age-old questions on origin of life, the finding may lead to new practical applications in chemistry and biology.

Groundbreaking Science.
Life-changing Medicine.